Sonneveld, P., Chanan-Khan, A., Weisel, K., Nooka, A., Masszi, T., Beksac, M., Spicka, I., Hungria, V., Munder, M., Mateos, M., Mark, T., Levin, M., Ahmadi, T., Qin, X., Garvin Mayo, W., Gai, X., Carey, J., Carson, R., & Spencer, A. (n.d.). p04: DARATUMUMAB PLUS BORTEZOMIB AND DEXAMETHASONE VERSUS BORTEZOMIB AND DEXAMETHASONE ALONE IN PATIENTS WITH PREVIOUSLY TREATED MULTIPLE MYELOMA: OVERALL SURVIVAL RESULTS FROM THE PHASE 3 CASTOR TRIAL. HemaSphere, 6, 12. http://access.bl.uk/ark:/81055/vdc_100153435583.0x000002